Irritable Bowel Syndrome News

From the impact of Humira biosimilars flooding the U.S. market to shifting trends in colorectal cancer demographics, Healio has asked experts the big questions to stay abreast of the current hot topics in gastroenterology and hepatology.

In this podcast episode, Tamara Duker Freuman, MS, RD, CDN, discusses how the work of gastroenterologists and dieticians can inform each other, approaching GI conditions as new science emerges and more.

A diagnosis of irritable bowel syndrome based on Rome IV criteria was “safe and durable,” with only 1% of patients diagnosed with a different gastrointestinal disease after rereferral and reinvestigation for ongoing IBS symptoms.

In my more than 30-year career as a registered dietitian in gastroenterology, it has been exciting to see the role of dietitians in gastrointestinal conditions become validated and expanded upon, most markedly over the past 10 years.

Irritable bowel syndrome is a dysfunction in the communication pathway between the gut and the brain, which contributes to symptoms such as gas, bloating, abdominal pain, diarrhea, constipation and mixed bowel habits.

Compared with the systemic calcineurin inhibitor standard cyclosporine, tacrolimus shows promise for numerous dermatologic conditions, whereas the literature on voclosporin is limited, according to a study.

Healio will present its sixth annual Disruptive Innovators Awards for gastroenterology and hepatology this fall.

A U.S. District Court judge in Delaware has denied Norwich Pharmaceuticals’ motion to modify the court’s final judgment, which blocks the FDA from approving their 550 mg rifaximin generic until Oct. 2, 2029.

CHICAGO — Digital gut-directed hypnotherapy resulted in greater improvement in abdominal pain and stool symptoms in patients with irritable bowel syndrome compared with digital muscle relaxation, according to research.

Anthony Lembo, MD, Director of Research for Cleveland Clinic's Digestive Disease & Surgery Institute, discusses the diagnostic process for patients presenting with constipation; approaching management of patients with IBS-C and CIC; treatment options and recent therapeutic advances; health disparities; and important challenges of care.